Charles Schwab’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-12,319
| Closed | -$52K | – | 3564 |
|
|
2022
Q2 | $52K | Hold |
12,319
| – | – | ﹤0.01% | 3388 |
|
|
2022
Q1 | $47K | Hold |
12,319
| – | – | ﹤0.01% | 3536 |
|
|
2021
Q4 | $56K | Hold |
12,319
| – | – | ﹤0.01% | 3503 |
|
|
2021
Q3 | $58K | Sell |
12,319
-22,008
| -64% | -$104K | ﹤0.01% | 3433 |
|
|
2021
Q2 | $243K | Sell |
34,327
-21,558
| -39% | -$153K | ﹤0.01% | 3259 |
|
|
2021
Q1 | $331K | Buy |
55,885
+1,780
| +3% | +$10.5K | ﹤0.01% | 3217 |
|
|
2020
Q4 | $250K | Sell |
54,105
-941
| -2% | -$4.35K | ﹤0.01% | 3227 |
|
|
2020
Q3 | $215K | Buy |
55,046
+9,601
| +21% | +$37.5K | ﹤0.01% | 3155 |
|
|
2020
Q2 | $1.31M | Buy |
45,445
+15,570
| +52% | +$448K | ﹤0.01% | 2553 |
|
|
2020
Q1 | $643K | Sell |
29,875
-3,640
| -11% | -$78.3K | ﹤0.01% | 2624 |
|
|
2019
Q4 | $660K | Buy |
+33,515
| New | +$660K | ﹤0.01% | 2721 |
|